Overview

Continuos Terlipressin Infusion in Septic Shock

Status:
Unknown status
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of terlipressin for treating septic shock.
Phase:
N/A
Details
Lead Sponsor:
First Affiliated Hospital, Sun Yat-Sen University
Collaborators:
Anhui Provincial Hospital
Beijing 302 Hospital
China Medical University, China
Chinese PLA General Hospital
First Affiliated Hospital Bengbu Medical College
First People's Hospital of Foshan
Guangdong Province, Department of Science and Technology
Guangxi Medical University
Hainan People's Hospital
Health Science Center of Xi'an Jiaotong University
Health Science Center of Xi’an Jiaotong University
Jinling Hospital, China
Second Affiliated Hospital, Sun Yat-Sen University
Shanghai Changzheng Hospital
Sixth Affiliated Hospital, Sun Yat-sen University
West China Hospital
Wuhan Union Hospital, China
Xiangya Hospital of Central South University
ZhuHai Hospital
Treatments:
Lypressin
Norepinephrine
Terlipressin